Karim Mohamed Abdalla Ziyada; Donya Vatanzadeh; Asghar Beigi Harchegegani; Eisa Tahmasbpour Marzouni; Mahdi Ghatrehsamani; Issa Layali; Mohammad Mahdi Jaafarzadeh; Saeid Rahmanzadeh
Volume 25, Issue 3 , 2023
Abstract
Background: Post-treatment nursing care is essential for patients with venous malformations (VMs) after they have undergone treatment. Effective post-treatment nursing care requires adequate resources, effective communication, patient compliance, and addressing psychological distress. However, the clinical ...
Read More
Background: Post-treatment nursing care is essential for patients with venous malformations (VMs) after they have undergone treatment. Effective post-treatment nursing care requires adequate resources, effective communication, patient compliance, and addressing psychological distress. However, the clinical care plan for VMs in the pharyngeal isthmus is not clear.
Objectives: The present study aims to explore the clinical nursing strategy after the treatment of VMs in the pharynx area.
Methods: In this study, the patients with VM in the pharynx region who received anhydrous ethanol sclerosis injection and/or surgical treatment in our Hospital from January 2013 to November 2018 were recruited. A total of 143 patients who had completed medical records were included in this prospective cohort study. The patients' post-operative vital signs were closely observed, the respiratory tract was maintained, the oral cavity was cleaned, and the nursing care of indwelling endotracheal intubation or tracheotomy was performed. After the clinical follow-ups of one to five years, long-term efficacy was also observed. We summarized their nursing care treatments.
Results: The results showed that there were 0 patients rated as grade I, 3 patients rated as grade II, 17 patients rated as grade III, and 123 patients rated as grade IV after long-term efficacy.
Conclusion: Appropriate anhydrous ethanol sclerotherapy can be selected for patients with pharyngeal venous malformation, and this method combined with the clinical nursing strategy after treatment concluded in this study can effectively reduce the volume of VM, with fewer side effects, and can effectively improve breathing, swallowing, and vocal function.
Ali Momeni; Masoud Amiri; Mahdi Ghatrehsamani; Maryam Mohammadi; Morteza Hashemzadeh Chaleshtori; Alireza Nematolahi
Volume 24, Issue 3 , 2022
Abstract
Background: Gene polymorphism of angiotensin-converting enzyme (ACE) may be associated with adverse prognosis and increased cardiovascular complications in hemodialysis patients.
Objectives: This study aimed to compare the frequency of ACE gene polymorphism in both hemodialysis patients and normal individuals ...
Read More
Background: Gene polymorphism of angiotensin-converting enzyme (ACE) may be associated with adverse prognosis and increased cardiovascular complications in hemodialysis patients.
Objectives: This study aimed to compare the frequency of ACE gene polymorphism in both hemodialysis patients and normal individuals considering echocardiographic findings.
Methods: This cross-sectional study included 110 hemodialysis patients (case) and 113 healthy subjects (control). Gene polymorphism of ACE was evaluated in both groups. ECG and echocardiography tests were performed for all patients. Correlations between gene polymorphisms and other variables were analyzed in this study. Polymerase chain reaction (PCR) was used to identify the short deletion allele (D with 190bp), large insertion allele (I with 490bp), and ID genotype which has both alleles.
Results: Case and control groups included 46 and 54 female and 64 and 59 male patients, respectively. There were no significant differences between the prevalence of DD, II, and DI alleles of the ACE gene with DI as the most common allele in both groups. No significant differences were found between systolic and diastolic blood pressure and heart rate in DD, DI, and II alleles of the case group. Echocardiographic findings of the patients showed no significant differences between DD, DI, and II genotypes of the case group and intraventricular septal end-diastole (IVSd), MVE vel, MVA vel, MVE/A ratio, MV DT, and MV Dec slope. The mean±SD left ventricular end-diastolic diameter (LVEDD) in II, ID, and DD patients were 4.3±0.72, 4.52±0.66, and 4.89±0.93 respectively (P=0.046).
Conclusion: The findings of the present study showed that there were no differences in the prevalence of alleles of an ACE gene in hemodialysis patients and control groups. Moreover, no significant associations were observed between alleles of an ACE gene in the patients' group and echocardiographic findings except in left ventricular end-diastolic diameter.
